Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
The high mortality rate associated with hepatocellular carcinoma (HCC) is partly due to the high proportion of patients who present with advanced stage disease at diagnosis, for whom there are limited treatment options. For selected patients with initially unresectable HCC, locoregional and/or syste...
Guardado en:
Autores principales: | Hui-Chuan Sun, Xiao-Dong Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c197caccee3141ceb94e64c53f8d2640 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
por: Xinyu Chen, et al.
Publicado: (2021) -
Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study
por: Jinliang Zhang, et al.
Publicado: (2021) -
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020) -
Unresectable hepatoblastoma: current perspectives
por: Trobaugh-Lotrario AD, et al.
Publicado: (2017) -
Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Laura Crocetti, et al.
Publicado: (2021)